Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lichen planus, Nodule, Rash
Clinical narrative: the number of nodules appearing have increased and have occurred in areas that do not normally show the nodules including his palms, legs, feet, back, scalp, hands, and groin.; the number of nodules appearing have increased and have occurred in areas that do not normally show the nodules including his palms, legs, feet, back, scalp, hands, and groin.; a lot of itchiness in my chin; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) via medical information team. The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Lichen planus" (unspecified if ongoing), notes: Caller reports having a history of lichen planus for many years. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, ), for COVID-19 Immunization, reaction(s): "No side effects". The following information was reported: LICHEN PLANUS (non-serious), SKIN MASS (non-serious), outcome "unknown" and all described as "the number of nodules appearing have increased and have occurred in areas that do not normally show the nodules including his palms, legs, feet, back, scalp, hands, and groin."; PRURITUS (non-serious), outcome "unknown", described as "a lot of itchiness in my chin". Therapeutic measures were taken as a result of lichen planus, skin mass.  Additional information: Product: Comirnaty. Question: Caller transferred from (withheld) (withheld) report reference (withheld). Caller is a Consumer. Pfizer covid 19 vaccine/Comirnaty confirmed.  Caller declined to file a report with (withheld). Caller reports having a history of lichen planus for many years. After having his second dose of the vaccine, caller said the number of nodules appearing have increased and have occurred in areas that do not normally show the nodules including his palms, legs, feet, back, scalp, hands, and groin. Caller reports also having "a lot of itchiness in my chin". Caller says clobetasol is used to typically treat his nodules. Caller has talked with his dermatologist. Caller would like to know if this is a known condition of the vaccine and if there are recommendations for his side effects. Caller referred to a study from the (withheld) that showed 414 similar cases, providing the website for reference: E-transmitting to (withheld) with AE information. Caller is male. Age not asked. Response: Searched (LAB; Revised: 20Oct2021) for "nodules", "lichen planus". Provided caller with Safety: Adverse Reactions or Side Effects response from the attached, including sharing Pfizer cannot assess causality between his adverse event and the vaccine. Treatment disclaimer stated. Encouraged caller to file a safety report. Caller did not wish to complete a report with (withheld) at this time. Provided caller with (withheld) upon his request. Referred caller to HCP. Survey offered. Request Name: (withheld), Product: COMIRNATY, Question: Caller wanted to ensure Pfizer is aware of the side effect of increased nodules, possibly related to the condition lichen planus and that there is an (withheld) study finding 414 cases. Caller expressed frustration that Pfizer did not have any information regarding his side effect from the vaccine saying "I'm surprised you do not know about it". Caller said if "I can do a (internet site) search and find out", then information should be available from Pfizer. Caller said he has "an obligation" to share his adverse event with Pfizer so that it can help others. Response: Acknowledge caller comments. Apologized for his experienced. Shared that reporting adverse events is voluntary; thanked caller for sharing his experience with us. Confirmed for caller Pfizer does have an obligation to report adverse events related to the vaccine reported to us. The lot number for bnt162b2 was not provided and will be requested during follow up.